Modelling the relative cost-effectiveness of the RTS,S/AS01 malaria vaccine compared to investment in vector control or chemoprophylaxis. (2023)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2023.04.011
PubMed Identifier: 37080831
Publication URI: http://europepmc.org/abstract/MED/37080831
Type: Journal Article/Review
Volume: 41
Parent Publication: Vaccine
Issue: 20
ISSN: 0264-410X